TY - JOUR AU - Bateman, R. J. AU - Xiong, C. AU - Benzinger, T. L. AU - Fagan, A. M. AU - Goate, A. AU - Fox, N. C. PY - 2012 DA - 2012// TI - Clinical and biomarker changes in dominantly inherited Alzheimer’s disease JO - N Engl J Med VL - 367 UR - https://doi.org/10.1056/NEJMoa1202753 DO - 10.1056/NEJMoa1202753 ID - Bateman2012 ER - TY - JOUR AU - Sperling, R. A. AU - Aisen, P. S. AU - Beckett, L. A. AU - Bennett, D. A. AU - Craft, S. AU - Fagan, A. M. PY - 2011 DA - 2011// TI - Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease JO - Alzheimers Dement VL - 7 UR - https://doi.org/10.1016/j.jalz.2011.03.003 DO - 10.1016/j.jalz.2011.03.003 ID - Sperling2011 ER - TY - JOUR AU - Jack, C. R. AU - Bennett, D. A. AU - Blennow, K. AU - Carrillo, M. C. AU - Dunn, B. AU - Haeberlein, S. B. PY - 2018 DA - 2018// TI - NIA-AA Research Framework: toward a biological definition of Alzheimer’s disease JO - Alzheimers Dement VL - 14 UR - https://doi.org/10.1016/j.jalz.2018.02.018 DO - 10.1016/j.jalz.2018.02.018 ID - Jack2018 ER - TY - JOUR AU - Scheltens, P. AU - Blennow, K. AU - Breteler, M. M. AU - Strooper, B. AU - Frisoni, G. B. AU - Salloway, S. PY - 2016 DA - 2016// TI - Alzheimer’s disease JO - Lancet. VL - 388 UR - https://doi.org/10.1016/S0140-6736(15)01124-1 DO - 10.1016/S0140-6736(15)01124-1 ID - Scheltens2016 ER - TY - JOUR AU - Toledo, J. B. AU - Zetterberg, H. AU - Harten, A. C. AU - Glodzik, L. AU - Martinez-Lage, P. AU - Bocchio-Chiavetto, L. PY - 2015 DA - 2015// TI - Alzheimer’s disease cerebrospinal fluid biomarker in cognitively normal subjects JO - Brain. VL - 138 UR - https://doi.org/10.1093/brain/awv199 DO - 10.1093/brain/awv199 ID - Toledo2015 ER - TY - JOUR AU - Nakamura, A. AU - Kaneko, N. AU - Villemagne, V. L. AU - Kato, T. AU - Doecke, J. AU - Dore, V. PY - 2018 DA - 2018// TI - High performance plasma amyloid-beta biomarkers for Alzheimer’s disease JO - Nature. VL - 554 UR - https://doi.org/10.1038/nature25456 DO - 10.1038/nature25456 ID - Nakamura2018 ER - TY - JOUR AU - Ovod, V. AU - Ramsey, K. N. AU - Mawuenyega, K. G. AU - Bollinger, J. G. AU - Hicks, T. AU - Schneider, T. PY - 2017 DA - 2017// TI - Amyloid beta concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis JO - Alzheimers Dement VL - 13 UR - https://doi.org/10.1016/j.jalz.2017.06.2266 DO - 10.1016/j.jalz.2017.06.2266 ID - Ovod2017 ER - TY - STD TI - Nabers A, Perna L, Lange J, Mons U, Schartner J, Guldenhaupt J, et al. Amyloid blood biomarker detects Alzheimer’s disease. EMBO Mol Med. 2018;10(5):e8763. ID - ref8 ER - TY - JOUR AU - Janelidze, S. AU - Stomrud, E. AU - Palmqvist, S. AU - Zetterberg, H. AU - Westen, D. AU - Jeromin, A. PY - 2016 DA - 2016// TI - Plasma beta-amyloid in Alzheimer’s disease and vascular disease JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep26801 DO - 10.1038/srep26801 ID - Janelidze2016 ER - TY - JOUR AU - Verberk, I. M. W. AU - Slot, R. E. AU - Verfaillie, S. C. J. AU - Heijst, H. AU - Prins, N. D. AU - Berckel, B. N. M. PY - 2018 DA - 2018// TI - Plasma amyloid as prescreener for the earliest Alzheimer pathological changes JO - Ann Neurol VL - 84 UR - https://doi.org/10.1002/ana.25334 DO - 10.1002/ana.25334 ID - Verberk2018 ER - TY - STD TI - Vergallo A, Megret L, Lista S, Cavedo E, Zetterberg H, Blennow K, et al. Plasma amyloid beta 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer’s disease. Alzheimers Dement. 2019;15(6):764–75. ID - ref11 ER - TY - STD TI - Palmqvist S, Janelidze S, Stomrud E, Zetterberg H, Karl J, Zink K, et al. Performance of fully automated plasma assays as screening tests for Alzheimer disease-related beta-amyloid status. JAMA Neurol. 2019;76(9):1060–9. ID - ref12 ER - TY - JOUR AU - Shahpasand-Kroner, H. AU - Klafki, H. W. AU - Bauer, C. AU - Schuchhardt, J. AU - Huttenrauch, M. AU - Stazi, M. PY - 2018 DA - 2018// TI - A two-step immunoassay for the simultaneous assessment of Abeta38, Abeta40 and Abeta42 in human blood plasma supports the Abeta42/Abeta40 ratio as a promising biomarker candidate of Alzheimer’s disease JO - Alzheimers Res Ther VL - 10 UR - https://doi.org/10.1186/s13195-018-0448-x DO - 10.1186/s13195-018-0448-x ID - Shahpasand-Kroner2018 ER - TY - JOUR AU - Shi, Y. AU - Lu, X. AU - Zhang, L. AU - Shu, H. AU - Gu, L. AU - Wang, Z. PY - 2019 DA - 2019// TI - Potential value of plasma amyloid-beta, total tau, and neurofilament light for identification of early Alzheimer’s disease JO - ACS Chem Neurosci VL - 10 UR - https://doi.org/10.1021/acschemneuro.9b00095 DO - 10.1021/acschemneuro.9b00095 ID - Shi2019 ER - TY - JOUR AU - Li, W. W. AU - Shen, Y. Y. AU - Tian, D. Y. AU - Bu, X. L. AU - Zeng, F. AU - Liu, Y. H. PY - 2019 DA - 2019// TI - Brain amyloid-beta deposition and blood biomarkers in patients with clinically diagnosed Alzheimer’s disease JO - J Alzheimers Dis VL - 69 UR - https://doi.org/10.3233/JAD-190056 DO - 10.3233/JAD-190056 ID - Li2019 ER - TY - JOUR AU - Chatterjee, P. AU - Elmi, M. AU - Goozee, K. AU - Shah, T. AU - Sohrabi, H. R. AU - Dias, C. B. PY - 2019 DA - 2019// TI - Ultrasensitive detection of plasma amyloid-beta as a biomarker for cognitively normal elderly individuals at risk of Alzheimer’s disease JO - J Alzheimers Dis VL - 71 UR - https://doi.org/10.3233/JAD-190533 DO - 10.3233/JAD-190533 ID - Chatterjee2019 ER - TY - STD TI - Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Li Y, Gordon BA, et al. High-precision plasma beta-amyloid 42/40 predicts current and future brain amyloidosis. Neurology. 2019;93(17):e1647–59. ID - ref17 ER - TY - JOUR AU - Wilson, D. H. AU - Rissin, D. M. AU - Kan, C. W. AU - Fournier, D. R. AU - Piech, T. AU - Campbell, T. G. PY - 2016 DA - 2016// TI - The Simoa HD-1 analyzer: a novel fully automated digital immunoassay analyzer with single-molecule sensitivity and multiplexing JO - J Lab Autom VL - 21 UR - https://doi.org/10.1177/2211068215589580 DO - 10.1177/2211068215589580 ID - Wilson2016 ER - TY - JOUR AU - Khalil, M. AU - Teunissen, C. E. AU - Otto, M. AU - Piehl, F. AU - Sormani, M. P. AU - Gattringer, T. PY - 2018 DA - 2018// TI - Neurofilaments as biomarkers in neurological disorders JO - Nat Rev Neurol VL - 14 UR - https://doi.org/10.1038/s41582-018-0058-z DO - 10.1038/s41582-018-0058-z ID - Khalil2018 ER - TY - STD TI - Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE, and the NFLG, et al. Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis. JAMA Neurol. 2019;76(9):1035–48. ID - ref20 ER - TY - JOUR AU - Mattsson, N. AU - Andreasson, U. AU - Zetterberg, H. AU - Blennow, K. PY - 2017 DA - 2017// TI - Alzheimer’s disease neuroimaging I. Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease JO - JAMA Neurol VL - 74 UR - https://doi.org/10.1001/jamaneurol.2016.6117 DO - 10.1001/jamaneurol.2016.6117 ID - Mattsson2017 ER - TY - JOUR AU - Lewczuk, P. AU - Ermann, N. AU - Andreasson, U. AU - Schultheis, C. AU - Podhorna, J. AU - Spitzer, P. PY - 2018 DA - 2018// TI - Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease JO - Alzheimers Res Ther VL - 10 UR - https://doi.org/10.1186/s13195-018-0404-9 DO - 10.1186/s13195-018-0404-9 ID - Lewczuk2018 ER - TY - JOUR AU - Zhou, W. AU - Zhang, J. AU - Ye, F. AU - Xu, G. AU - Su, H. AU - Su, Y. PY - 2017 DA - 2017// TI - Plasma neurofilament light chain levels in Alzheimer’s disease JO - Neurosci Lett VL - 650 UR - https://doi.org/10.1016/j.neulet.2017.04.027 DO - 10.1016/j.neulet.2017.04.027 ID - Zhou2017 ER - TY - JOUR AU - Hu, H. AU - Chen, K. L. AU - Ou, Y. N. AU - Cao, X. P. AU - Chen, S. D. AU - Cui, M. PY - 2019 DA - 2019// TI - Neurofilament light chain plasma concentration predicts neurodegeneration and clinical progression in nondemented elderly adults JO - Aging (Albany NY) VL - 11 UR - https://doi.org/10.18632/aging.102220 DO - 10.18632/aging.102220 ID - Hu2019 ER - TY - JOUR AU - Preische, O. AU - Schultz, S. A. AU - Apel, A. AU - Kuhle, J. AU - Kaeser, S. A. AU - Barro, C. PY - 2019 DA - 2019// TI - Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease JO - Nat Med VL - 25 UR - https://doi.org/10.1038/s41591-018-0304-3 DO - 10.1038/s41591-018-0304-3 ID - Preische2019 ER - TY - JOUR AU - Weston, P. S. J. AU - Poole, T. AU - Ryan, N. S. AU - Nair, A. AU - Liang, Y. AU - Macpherson, K. PY - 2017 DA - 2017// TI - Serum neurofilament light in familial Alzheimer disease: a marker of early neurodegeneration JO - Neurology. VL - 89 UR - https://doi.org/10.1212/WNL.0000000000004667 DO - 10.1212/WNL.0000000000004667 ID - Weston2017 ER - TY - JOUR AU - Oeckl, P. AU - Halbgebauer, S. AU - Anderl-Straub, S. AU - Steinacker, P. AU - Huss, A. M. AU - Neugebauer, H. PY - 2019 DA - 2019// TI - Glial fibrillary acidic protein in serum is increased in Alzheimer’s disease and correlates with cognitive impairment JO - J Alzheimers Dis VL - 67 UR - https://doi.org/10.3233/JAD-180325 DO - 10.3233/JAD-180325 ID - Oeckl2019 ER - TY - JOUR AU - Ishiki, A. AU - Kamada, M. AU - Kawamura, Y. AU - Terao, C. AU - Shimoda, F. AU - Tomita, N. PY - 2016 DA - 2016// TI - Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer’s disease, dementia with Lewy bodies, and frontotemporal lobar degeneration JO - J Neurochem VL - 136 UR - https://doi.org/10.1111/jnc.13399 DO - 10.1111/jnc.13399 ID - Ishiki2016 ER - TY - JOUR AU - Fukuyama, R. AU - Izumoto, T. AU - Fushiki, S. PY - 2001 DA - 2001// TI - The cerebrospinal fluid level of glial fibrillary acidic protein is increased in cerebrospinal fluid from Alzheimer’s disease patients and correlates with severity of dementia JO - Eur Neurol VL - 46 UR - https://doi.org/10.1159/000050753 DO - 10.1159/000050753 ID - Fukuyama2001 ER - TY - JOUR AU - Jesse, S. AU - Steinacker, P. AU - Cepek, L. AU - Arnim, C. A. AU - Tumani, H. AU - Lehnert, S. PY - 2009 DA - 2009// TI - Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer’s disease and Creutzfeldt-Jakob disease JO - J Alzheimers Dis VL - 17 UR - https://doi.org/10.3233/JAD-2009-1075 DO - 10.3233/JAD-2009-1075 ID - Jesse2009 ER - TY - JOUR AU - Abu-Rumeileh, S. AU - Steinacker, P. AU - Polischi, B. AU - Mammana, A. AU - Bartoletti-Stella, A. AU - Oeckl, P. PY - 2019 DA - 2019// TI - CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia JO - Alzheimers Res Ther VL - 12 UR - https://doi.org/10.1186/s13195-019-0562-4 DO - 10.1186/s13195-019-0562-4 ID - Abu-Rumeileh2019 ER - TY - JOUR AU - Nagele, R. G. AU - D’Andrea, M. R. AU - Lee, H. AU - Venkataraman, V. AU - Wang, H. Y. PY - 2003 DA - 2003// TI - Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains JO - Brain Res VL - 971 UR - https://doi.org/10.1016/S0006-8993(03)02361-8 DO - 10.1016/S0006-8993(03)02361-8 ID - Nagele2003 ER - TY - JOUR AU - Simpson, J. E. AU - Ince, P. G. AU - Lace, G. AU - Forster, G. AU - Shaw, P. J. AU - Matthews, F. PY - 2010 DA - 2010// TI - Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain JO - Neurobiol Aging VL - 31 UR - https://doi.org/10.1016/j.neurobiolaging.2008.05.015 DO - 10.1016/j.neurobiolaging.2008.05.015 ID - Simpson2010 ER - TY - JOUR AU - Garwood, C. J. AU - Ratcliffe, L. E. AU - Simpson, J. E. AU - Heath, P. R. AU - Ince, P. G. AU - Wharton, S. B. PY - 2017 DA - 2017// TI - Review: astrocytes in Alzheimer’s disease and other age-associated dementias: a supporting player with a central role JO - Neuropathol Appl Neurobiol VL - 43 UR - https://doi.org/10.1111/nan.12338 DO - 10.1111/nan.12338 ID - Garwood2017 ER - TY - JOUR AU - Hondius, D. C. AU - Nierop, P. AU - Li, K. W. AU - Hoozemans, J. J. AU - Schors, R. C. AU - Haastert, E. S. PY - 2016 DA - 2016// TI - Profiling the human hippocampal proteome at all pathologic stages of Alzheimer’s disease JO - Alzheimers Dement VL - 12 UR - https://doi.org/10.1016/j.jalz.2015.11.002 DO - 10.1016/j.jalz.2015.11.002 ID - Hondius2016 ER - TY - JOUR AU - Flier, W. M. AU - Pijnenburg, Y. A. AU - Prins, N. AU - Lemstra, A. W. AU - Bouwman, F. H. AU - Teunissen, C. E. PY - 2014 DA - 2014// TI - Optimizing patient care and research: the Amsterdam dementia cohort JO - J Alzheimers Dis VL - 41 UR - https://doi.org/10.3233/JAD-132306 DO - 10.3233/JAD-132306 ID - Flier2014 ER - TY - JOUR AU - Flier, W. M. AU - Scheltens, P. PY - 2018 DA - 2018// TI - Amsterdam dementia cohort: performing research to optimize care JO - J Alzheimers Dis VL - 62 UR - https://doi.org/10.3233/JAD-170850 DO - 10.3233/JAD-170850 ID - Flier2018 ER - TY - JOUR AU - Jessen, F. AU - Amariglio, R. E. AU - Boxtel, M. AU - Breteler, M. AU - Ceccaldi, M. AU - Chetelat, G. PY - 2014 DA - 2014// TI - A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease JO - Alzheimers Dement VL - 10 UR - https://doi.org/10.1016/j.jalz.2014.01.001 DO - 10.1016/j.jalz.2014.01.001 ID - Jessen2014 ER - TY - JOUR AU - Petersen, R. C. AU - Smith, G. E. AU - Waring, S. C. AU - Ivnik, R. J. AU - Tangalos, E. G. AU - Kokmen, E. PY - 1999 DA - 1999// TI - Mild cognitive impairment: clinical characterization and outcome JO - Arch Neurol VL - 56 UR - https://doi.org/10.1001/archneur.56.3.303 DO - 10.1001/archneur.56.3.303 ID - Petersen1999 ER - TY - JOUR AU - Albert, M. S. AU - DeKosky, S. T. AU - Dickson, D. AU - Dubois, B. AU - Feldman, H. H. AU - Fox, N. C. PY - 2011 DA - 2011// TI - The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease JO - Alzheimers Dement VL - 7 UR - https://doi.org/10.1016/j.jalz.2011.03.008 DO - 10.1016/j.jalz.2011.03.008 ID - Albert2011 ER - TY - JOUR AU - McKhann, G. AU - Drachman, D. AU - Folstein, M. AU - Katzman, R. AU - Price, D. AU - Stadlan, E. M. PY - 1984 DA - 1984// TI - Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease JO - Neurology. VL - 34 UR - https://doi.org/10.1212/WNL.34.7.939 DO - 10.1212/WNL.34.7.939 ID - McKhann1984 ER - TY - JOUR AU - McKhann, G. M. AU - Knopman, D. S. AU - Chertkow, H. AU - Hyman, B. T. AU - Jack, C. R. AU - Kawas, C. H. PY - 2011 DA - 2011// TI - The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease JO - Alzheimers Dement VL - 7 UR - https://doi.org/10.1016/j.jalz.2011.03.005 DO - 10.1016/j.jalz.2011.03.005 ID - McKhann2011 ER - TY - JOUR AU - Scheltens, P. AU - Leys, D. AU - Barkhof, F. AU - Huglo, D. AU - Weinstein, H. C. AU - Vermersch, P. PY - 1992 DA - 1992// TI - Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates JO - J Neurol Neurosurg Psychiatry VL - 55 UR - https://doi.org/10.1136/jnnp.55.10.967 DO - 10.1136/jnnp.55.10.967 ID - Scheltens1992 ER - TY - JOUR AU - Wilde, A. AU - Reimand, J. AU - Teunissen, C. E. AU - Zwan, M. AU - Windhorst, A. D. AU - Boellaard, R. PY - 2019 DA - 2019// TI - Discordant amyloid-beta PET and CSF biomarkers and its clinical consequences JO - Alzheimers Res Ther VL - 11 UR - https://doi.org/10.1186/s13195-019-0532-x DO - 10.1186/s13195-019-0532-x ID - Wilde2019 ER - TY - JOUR AU - Zwan, M. D. AU - Bouwman, F. H. AU - Konijnenberg, E. AU - Flier, W. M. AU - Lammertsma, A. A. AU - Verhey, F. R. PY - 2017 DA - 2017// TI - Diagnostic impact of [(18)F]flutemetamol PET in early-onset dementia JO - Alzheimers Res Ther VL - 9 UR - https://doi.org/10.1186/s13195-016-0228-4 DO - 10.1186/s13195-016-0228-4 ID - Zwan2017 ER - TY - JOUR AU - Slot, R. E. R. AU - Verfaillie, S. C. J. AU - Overbeek, J. M. AU - Timmers, T. AU - Wesselman, L. M. P. AU - Teunissen, C. E. PY - 2018 DA - 2018// TI - Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results JO - Alzheimers Res Ther VL - 10 UR - https://doi.org/10.1186/s13195-018-0390-y DO - 10.1186/s13195-018-0390-y ID - Slot2018 ER - TY - JOUR AU - Ossenkoppele, R. AU - Flier, W. M. AU - Verfaillie, S. C. AU - Vrenken, H. AU - Versteeg, A. AU - Schijndel, R. A. PY - 2014 DA - 2014// TI - Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions JO - Neurology. VL - 82 UR - https://doi.org/10.1212/WNL.0000000000000432 DO - 10.1212/WNL.0000000000000432 ID - Ossenkoppele2014 ER - TY - JOUR AU - Wilde, A. AU - Flier, W. M. AU - Pelkmans, W. AU - Bouwman, F. AU - Verwer, J. AU - Groot, C. PY - 2018 DA - 2018// TI - Association of amyloid positron emission tomography with changes in diagnosis and patient treatment in an unselected memory clinic cohort: the ABIDE project JO - JAMA Neurol. VL - 75 UR - https://doi.org/10.1001/jamaneurol.2018.1346 DO - 10.1001/jamaneurol.2018.1346 ID - Wilde2018 ER - TY - JOUR AU - Johnson-Wood, K. AU - Lee, M. AU - Motter, R. AU - Hu, K. AU - Gordon, G. AU - Barbour, R. PY - 1997 DA - 1997// TI - Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease JO - Proc Natl Acad Sci U S A VL - 94 UR - https://doi.org/10.1073/pnas.94.4.1550 DO - 10.1073/pnas.94.4.1550 ID - Johnson-Wood1997 ER - TY - JOUR AU - Verhage, F. PY - 1965 DA - 1965// TI - Intelligence and age in a Dutch sample JO - Hum Dev VL - 8 UR - https://doi.org/10.1159/000270308 DO - 10.1159/000270308 ID - Verhage1965 ER - TY - JOUR AU - Liddelow, S. A. AU - Guttenplan, K. A. AU - Clarke, L. E. AU - Bennett, F. C. AU - Bohlen, C. J. AU - Schirmer, L. PY - 2017 DA - 2017// TI - Neurotoxic reactive astrocytes are induced by activated microglia JO - Nature. VL - 541 UR - https://doi.org/10.1038/nature21029 DO - 10.1038/nature21029 ID - Liddelow2017 ER - TY - JOUR AU - Lewczuk, P. AU - Gaignaux, A. AU - Kofanova, O. AU - Ermann, N. AU - Betsou, F. AU - Brandner, S. PY - 2018 DA - 2018// TI - Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease JO - Alzheimers Res Ther VL - 10 UR - https://doi.org/10.1186/s13195-018-0418-3 DO - 10.1186/s13195-018-0418-3 ID - Lewczuk2018 ER - TY - JOUR AU - Rozga, M. AU - Bittner, T. AU - Batrla, R. AU - Karl, J. PY - 2019 DA - 2019// TI - Preanalytical sample handling recommendations for Alzheimer’s disease plasma biomarkers JO - Alzheimers Dement (Amst) VL - 11 UR - https://doi.org/10.1016/j.dadm.2019.02.002 DO - 10.1016/j.dadm.2019.02.002 ID - Rozga2019 ER - TY - JOUR AU - Vanderstichele, H. AU - Bibl, M. AU - Engelborghs, S. AU - Bastard, N. AU - Lewczuk, P. AU - Molinuevo, J. L. PY - 2012 DA - 2012// TI - Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer’s disease diagnosis: a consensus paper from the Alzheimer’s Biomarkers Standardization Initiative JO - Alzheimers Dement VL - 8 UR - https://doi.org/10.1016/j.jalz.2011.07.004 DO - 10.1016/j.jalz.2011.07.004 ID - Vanderstichele2012 ER - TY - JOUR AU - Mielke, M. M. AU - Syrjanen, J. A. AU - Blennow, K. AU - Zetterberg, H. AU - Vemuri, P. AU - Skoog, I. PY - 2019 DA - 2019// TI - Plasma and CSF neurofilament light: relation to longitudinal neuroimaging and cognitive measures JO - Neurology. VL - 93 UR - https://doi.org/10.1212/WNL.0000000000007767 DO - 10.1212/WNL.0000000000007767 ID - Mielke2019 ER - TY - JOUR AU - Mielke, M. M. AU - Hagen, C. E. AU - Xu, J. AU - Chai, X. AU - Vemuri, P. AU - Lowe, V. J. PY - 2018 DA - 2018// TI - Plasma phospho-tau181 increases with Alzheimer’s disease clinical severity and is associated with tau- and amyloid-positron emission tomography JO - Alzheimers Dement VL - 14 UR - https://doi.org/10.1016/j.jalz.2018.02.013 DO - 10.1016/j.jalz.2018.02.013 ID - Mielke2018 ER - TY - STD TI - Thijssen EH, La Joie R, Wolf A, Strom A, Wang P, Iaccarino L, et al. Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration. Nat Med. 2020;26(3):387–97. ID - ref57 ER - TY - STD TI - Ebenau JL, Timmers T, Wesselman LMP, Verberk IMW, Verfaillie SCJ, Slot RER, et al. ATN classification and clinical progression in subjective cognitive decline: the SCIENCe project. Neurology. 2020;95(1):e46–58. ID - ref58 ER -